Biotech entity
All 1 tracked stories fall under one category: pharma. Schrödinger is most often covered alongside Churchill Downs Incorporated, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Schrödinger, all published on February 26, 2026.
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Schrödinger is most often covered alongside Churchill Downs Incorporated, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Schrödinger, all published on February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Schrödinger. Shared-story counts are live from our verified record — not editorial picks.
GoodRx and Schrödinger released their full-year 2025 financial results, highlighting a critical period of transition for digital health and computational drug discovery. While GoodRx focused on stabilizing its prescription marketplace margins, Schrödinger demonstrated the growing scalability of its AI-driven software platform alongside its internal clinical pipeline.
Schrödinger is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
